Archangels, established in 1992 in Scotland, is the world's oldest business angel syndicate. The fund invests in start-up and early-stage companies in technology and life sciences, typically during the seed and Series A stages. Notable investments include Cytomos and Bio-Images Drug Delivery. Archangels seeks businesses with strong intellectual property in sectors such as biotech, health tech, and pharma.
